16th August 2019
During the event, EIT Health initiatives were promoted as well.
EIT Health Spain was present at the IX International BioSpain Biotechnology Meeting 2018, organised by the Spanish Association of Biocompanies (ASEBIO) and the Government of Andalusia. The event was held this year on 25-27 September, in the Palace of Congresses and Exhibitions of Seville.
The fair was inaugurated by the President of the Andalusian Government, Susana Díaz, and counted with more than 1,500 attendees, 600 companies and 200 exhibitors, confirming it as one of the reference events in the biotechnology and biomedicine field.This strategic opportunity to consolidate its role within the sector was what drove the EIT Health presence.
In addition to promoting the portfolio of health innovation, acceleration and training programmes with which the consortium intends to contribute to the improvement of the existing offer, the appointment also served to establish new contacts with key agents in the Spanish health ecosystem.
EIT Health Spain’s Managing Director, Marco Pugliese, met with representatives of the Basque and Galician healthcare public systems among others; while the Business Creation Manager, Irene Sánchez, prioritised meetings with emerging companies.
In total, almost 50 meetings were held, which in the future could materialise in new collaboration agreements. BioSpain brings together the main players in the biotechnology field among industry, research centres, universities, investors, service providers, and consultants.
The sector has become a growing engine of the industrial and technological development of the region. In fact, the sum of money generated by the biotechnology industry, which amounts to more than €7,000 million, represents 0.7% of the Spanish GDP, with Catalonia, Madrid, and Andalusia being the lead investors in the sector.
For further enquiries contact:
- Cristina Rubio, firstname.lastname@example.org
EIT Health Catapult 2021 selects 42 semi-finalists
Learn about these promising start-ups
EIT Health partners Warsaw Health Innovation Hub
A joint initiative between government and business
Will COVID-19 spark a cancer vaccine boom?
Using DNA vaccines to fight cancer